🔗 Share this article

An underground market for unapproved slimming drugs is being driven by social media fitness personalities and sellers on messaging platforms, according to new investigations.

Investigational Drug Acquiring Traction Via Social Media

The experimental drug, which remains in clinical trials, is being advertised by online personalities for its supposed fat-burning effects. Followers are urged to contact these accounts directly for source information, while also receiving discount codes.

Active Trade on Messaging Platforms

Additionally, a robust market exists on messaging services, where groups with thousands of participants share “before and after” photos, administration instructions and assertions of next-day British shipping. Sellers market the drug there before directing buyers to other platforms for transactions.

Learning About The Experimental Drug

Retatrutide is an investigational injection developed by US drugmaker Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, GIP and glucagon. Early trials indicate it could help individuals reduce up to 25% of their body weight. Nicknamed the “triple G”, the substance is being hailed online as the successor to Ozempic.

Healthcare Professionals Voice Concerns

Nevertheless, physicians and pharmacists have cautions that the sale of what is still an unlicensed medication in the United Kingdom is a cause for concern and could result in users administering products of uncertain source.

Some experts stated the demand for the experimental drug could be connected to the rising cost of approved weight loss treatments such as Mounjaro.

Regulatory Status and Implementation

Marketing retatrutide on social media or messaging apps is illegal in the UK, as it is an unlicensed drug that must not be promoted or supplied for human use under the British medical regulations.

Some content creators attempt to circumvent the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but advertising and supply can still breach medicines, advertising, and consumer laws, risking penalties, prosecution or imprisonment.

Service Response and Content Elimination

According to the social media company, the platform has removed problematic material and prohibited associated hashtags and query recommendations. The organization said it was dedicated to keeping the service safe and allocating resources in strengthening enforcement strategies.

Online Marketplace Activities

Research also discovered communities with up to nine thousand members marketing retatrutide using Telegram's integrated search feature, which functions like a online catalog. Entering “retatrutide” immediately displays groups with numerous of members, populated with photos of slimming results, glowing testimonials and step-by-step guides for mixing or injecting at residence.

After moments of entering one group, a seller posted WhatsApp details, where most purchases occur. The seller sent an guidebook and guaranteed shipping within two days. When questioned whether the product was authentic, one seller responded: “You can’t be sure.” Another provided a photo of a alleged testing documentation. None asked about weight, health issues or previous experience.

Product Details and Pricing

Inside these groups, messages display dark colored packages with Royal Mail labels, stating to include new batches. One message read: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, mixed at residence with purified liquid, or pre-filled injectors usually priced at 160 pounds for 20mg. When questioned how much time a pen should be used, sellers give contradictory responses varying between a few weeks to “depends on your body”.

Service Moderation and Safety Measures

A representative for Telegram said it actively moderated harmful material on its service including material that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“Individuals are administering materials they cannot confirm. Although the research behind this drug is valid, these digital products may not include what they advertise,” stated a pharmacy expert, the director of pharmacy at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor connected the surge in demand to current cost increases for approved slimming drugs such as Mounjaro. “With prices rising, patients are turning to social media. But fake injections are extremely risky. You can’t be certain what’s inside or whether the conditions they were produced in was sterile,” she explained.

Her staff has previously seen individuals injured by self-injection from unverified sources. “We recognize the frustration, but buying from Telegram or WhatsApp is gambling with your health,” said the doctor. “These materials could be contaminated or incorrectly dosed.”

Manufacturer Statement

A representative from Eli Lilly stated the substance was in third stage clinical trials and had not been evaluated or approved by any regulatory agency globally. “Therefore at this point no one can market [it] for personal consumption,” they explained, noting that any item “misleadingly claiming itself as a company experimental substance not yet approved … may expose patients to possibly significant health risks”.